Pursue Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Pursue Wealth Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,652	Closed	-$420K	–	116
2024 Q1	$420K	Hold	2,652	–	–	0.25%	68
2023 Q4	$416K	Sell	2,652 -1,279	-33%	-$196K	0.27%	64
2023 Q3	$612K	Sell	3,931 -1,391	-26%	-$230K	0.43%	51
2023 Q2	$881K	Buy	+5,322	New	+$859K	0.55%	45

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pursue Wealth Partners's JNJ Position: Q2 2024 in Review

Pursue Wealth Partners sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 2,652 shares — an estimated $420K sold.

Pursue Wealth Partners first reported a position in JNJ in Q2 2023 and held it in 4 quarters. The position peaked at $881K in Q2 2023. 3,802 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

Pursue Wealth Partners reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
Pursue Wealth Partners sold 2,652 Johnson & Johnson shares in Q2 2024, an estimated $420K.
Pursue Wealth Partners first reported a position in Johnson & Johnson in Q2 2023 and held it in 4 quarters.
Pursue Wealth Partners's Johnson & Johnson position peaked at $881K in Q2 2023.
3,802 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Pursue Wealth Partners's 13F filing for Q2 2024, filed 2 Aug 2024.